Skip to content
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR). Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) has seen […]...
Yahoo Finance’s Brian Sozzi, Alexis Christoforous and Andy Serwer discuss the market's poor reception to Uber’s IPO and meltdown at WeWork, on The First Trade....
Twitter said it would make it easier to report misleading information about the voting process in Britain's Dec. 12 election, less than a month after its global ban on political advertising comes into force. The microblogging site is a vital tool for candidates, political parties and journalists to break news and fuel debate, but it has also been used to spread fake news, such as manipulated video clips, and to abuse and threaten individuals. It said last month it would stop all political advertising, making the British election one of the first major tests for the new policy....
We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of June 28th. In this article, we look at what those funds think of GP Strategies Corporation (NYSE:GPX) based on that […]...
Anyone researching DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) might want to consider the historical volatility of the......
We can judge whether The Meet Group, Inc. (NASDAQ:MEET) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than to follow their lead into their best […]...
The company is considering possible partnerships with companies from the animal health pharmaceutical industry that could in-license and create Piclidenoson for the companion animal market. Canine osteoarthritis is being treated with oral non-steroidal anti-inflammatory drugs that only address symptoms and have damaging side effects, and an injectable disease modifying osteoarthritis drug which only affects the progression of the disease, according to the company. Click here to sign up for our daily insider newsletter....
